Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing, followed by ...
The FDA has announced the Rare Disease Framework Initiative, a broad effort to build a new regulatory approach tailored ...
Generating up to 100 times more antiviral drug candidates than was previously practical — in weeks rather than months or ...
The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using ...
Osteoporosis weakens bones and makes them more likely to break. The disease affects about 10 million Americans over age 50, ...
There has been much discussion recently about how artificial intelligence and machine learning (AI/ML) will revolutionize pharmaceutical research. Substantial progress has been made in the discovery ...
Thermo Fisher Scientific, the world leader in serving science, is expanding its drug development, manufacturing, and clinical capabilities to help pharmaceutical and biotechnology companies navigate ...
The medical marijuana competitive landscape report delivers important insights into approved as well as ongoing research of 65+ pipeline medical marijuana drugs, clinical strategies, upcoming ...
The hardest disease to care for when I was training as a pediatrician in the late 1970s was cystic fibrosis, a disease in ...
Progress in computing has long been described by Moore’s law, a rule of thumb which says that the cost of processing power falls by half roughly every two years. The pharmaceutical industry follows an ...
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a ...
Detailed analyses of ligand choice, linkage vector and linker length enabled the development of bitopic inhibitors of ABL1 and EGFR kinases, including an ABL1 inhibitor with enhanced activity against ...